Zosel Andrew Joseph reported DBD

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002121521-26-000003

Machine-readable

Structured copy

Timestamps

Event (reported)

Mar 1, 2026

Published

Mar 17, 2026

Ingested by INSIDER

Nov 5, 04:11 UTC

Last re-read

Nov 5, 04:11 UTC

Extracted facts

Filer

Zosel Andrew Joseph

Role

EVP, Chief Prod & Tech Officer

Transaction

Grant or awardAs filed: “A”

Asset

DIEBOLD NIXDORF, Inc

Ticker

DBD

Shares

6,561

Price per share

$0

Execution date (reported)

Mar 1, 2026

Owned after transaction

6,561 shares

Days from execution to publication

16

What this establishes

Zosel Andrew Joseph filed this Form 4 reporting a grant or award of DBD on Mar 1, 2026. It became public on Mar 17, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

EVP, Chief Prod & Tech Officer

Zosel Andrew Josephcik:0002121521

Issuer

DIEBOLD NIXDORF, Inccik:0000028823

Revision history · 0

No field has changed since this record was first ingested.